March Biosciences (March Bio), a clinical stage biotechnology company developing cell therapies for hard-to-treat cancers, today announced that the U.S. Food and Drug Administration (FDA) has granted ...
The Houston-based hospital system is one of hundreds of health care providers suing the nation's largest insurers. Claritev, ...
Denise L. Anthony ([email protected]) is a professor of health management and policy and of sociology in the Department of Health Management and Policy, University of Michigan School of Public Health, ...
Methodist Midlothian Medical Center celebrates its five year anniversary and announces exciting ER expansion project.
BOSTON — As the use of biologic drugs becomes more widespread, optometrists need to be aware of the downstream impacts they could have on patients’ ocular health, according to speakers here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback